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The etiology of Ccl,-intoxication and the known metabolic effects of chloramphenicol suggest the following possible loci for protection by chloramphenicol.
(a) Mitochondrial protein synthesis : Chloramphenicol inhibits mitochondrial protein synthesis, and is reported to bind to the acceptor site of the 50 S ribosomal subunit (Contreras et al., 1974) . A novel possibility is that the biosynthetic operations of the mitochondrion in the Ccl,-traumatized hepatocyte are impaired and mitochondrial dysfunction results from the accumulation of protein(s). Chloramphenicol would prevent such an accumulation, and thereby the incipient mitochondrial lesion. Such a mechanism has been offered to explain the protection cycloheximide offers cells of the intestinal crypt after X-irradiation (Lieberman et al., 1970) . (b) Ccl, metabolism: The initial molecular lesion induced by Ccl, is thought to be the result of the production of an activated metabolite of CC& by microsomal enzymes. The activated metabolite is postulated to bind to an adjacent membrane molecule, disrupting function (Reynolds, 1972) , or to initiate a homolytic lipid peroxidation of the unsaturated fatty acids of the phospholipids in the membrane (Recknagel et al., 1974) . Chloramphenicol has been reported to be an inhibitor of the N-dealkylation of aminopyrine in vitro (Dixon and Fouts, 1962) and to prolong the sleeping time of hexobarbital-exposed rats (Grogan et al., 1972) . Chloramphenicol decreases the formation of CHCI, from Ccl, in rats (Huyen and Banaschak, 1973) . The theory that toxicity results from the metabolism of Ccl, would predict a protective action by chloramphenicol due to inhibition of Ccl, metabolism. The purpose of this study was to elucidate the antagonism of CCl,-intoxication by chloramphenicol.
METHODS
White laboratory rats, CFN strain, weighing 180-250 g, were used. Ccl, was injected ip, without carrier, at 1.2 ml/kg, a dose that permitted 80 % of the animals to survive the intoxication. The sodium succinyl salt of chloramphenicol and SKF 525A3 were dissolved in distilled water, 100 mg/kg, and given ip at the indicated dose regimen. Typically, the animals received Ccl, followed immediately by 100 mg/kg of chloramphenicol, and were sacrificed 40 hr later. D-CAP, L-CAP (the respective optical isomers of three-chloramphenicol) and Tevenel (a sulfamoyl analog of chloramphenicol) were dissolved, 50 mg/ml, in propylene glycol and administered ip at selected doses as indicated. Oxytetracycline dissolved in propylene glycol, 50 mg/ml, was also injected ip4.
Mitochondria, prepared from rat livers, were assayed polarographically in an YSI Model 53 Biological Oxygen Monitor as previously described (Brabec et al., 1974) . The respiratory control ratio was calculated from the State 3 (+ADP) and State 4 (-ADP) oxygen uptake rates as described by Estabrook (1967) . Mitochondrial protein was determined by the Biuret method (Jacobs et al., 1956 ).
Incorporation of amino acids was determined in animals injected ip with 50 ,Ki per 200 g body weight [3,4-3H] leucine (sp act 60 Ci/mmol) either 4.5 or 25.5 hr after Ccl, administration (30 min prior to sacrifice). The mitochondria were prepared, and acidinsoluble radioactivity was determined by a modification of the method of Mans and Novelli (1961) . The mitochondrial suspension was diluted with 0.05 M L-leucine to a concentration of 10 mg/ml and sonicated 1 min at 8 A on a Bronson Sonifier, Model LS-75. Approximately 0.8 mg of mitochondrial protein was streaked on l-x 6-cm strips of Whatman # 1 filter paper and immediately submerged in ice-cold 10 % TCA-0.025 M L-leucine for 30 min. The strips were then successively transfered at 15-min intervals through the following solutions at the indicated temperatures (CO): 10% TCA, 0"; 10 % TCA, 90"; 5 % TCA, 0"; ethanolether, 20". The strips were then dryed in an oven, placed in 8 ml of a scintillation cocktail (Packard Permablend I), and counted in a Packard Tri-Carb liquid scintillation counter. Net counts per minute were recorded. Controls, which had received 100 mg/kg of D-CAPS 4.5 or 26.5 hr prior to [3,4-3H] leucine, were not significantly different from nonintoxicated controls in incorporation rates.
Incorporation of amino acids into acid-insoluble protein by isolated mitochondria was determined by the procedure of Simpson et al. (1967) , as described previously (Brabec et al., 1974) . Mitochondria were prepared aseptically from animals which had been pretreated with D-CAPS or oxytetracycline at selected doses and times. After incubation with [U-14C]leucine (sp act 326Ci/mol), the mitochondrial suspension was washed free of soluble [14C]leucine and the acid-insoluble radioactivity was determined as described above. Bacterial contamination, monitored by streaking an aliquot of the incubation mixture on nutrient agar plates and incubating for 24 hr at 37°C was always less than 500 colonies/ml of incubation mixture.
Statistical analysis. The ability of a selected drug to prevent mitochondrial damage suffered during exposure to CCI, was evaluated by use of the Student's t test (Schefler, 1969) .
RESULTS
The respiratory control ratio (RCR) was monitored as an indicator of mitochondrial integrity. The appearance of mitochondrial damage was marked by a decline of the RCR, due to an increase in the State 4 (-ADP) rate, and a decrease in the State 3 (+ADP) rate, as is shown in Fig. 1 . Since maximum damage was noted at 40 hr after administration of Ccl,, and recovery in the RCR values began at 40-50 hr, mitochondria for these studies were prepared from rats after 36-40 hr of intoxication. The RCR values for animals similarly treated with Ccl,, but having received 100 mg/kg of D-CAPS at 0 time, are also displayed in Fig. 1 . Only a slight decline in the RCR was noted. Mortality of the experimental animals provides another estimation of protection. During these experiments, 72 % of the intoxicated animals (53 of 73 experimental animals) and 98 % of the protected animals (59 of 60) survived at least 40 hr.
Protection by D-CAPS as a function of dosage is shown in Fig. 2 . Below 50 mg/kg protection declined rapidly, with slight protection offered by 25 mg/kg D-CAPS. Since mitochondrial dysfunction is a late development during Ccl, intoxication (RCR values are normal for the first 10 hr after Ccl, exposure), the ability of D-CAPS to protect as a function of time after the administration of CC& is critical to the consideration of possible protective mechanisms. As seen in Fig. 3 , for any protection, D-CAPS had to be delivered to the intoxicated rat within 7 hr after the animal had received the ccl,.
A system was devised to determine whether the inhibition of mitochondrial protein synthesis was a possible mechanism for protection. If inhibition of mitochondrial protein synthesis were the mechanism by which D-CAP prevents mitochondrial damage during CCL, intoxication, the model would predict that other inhibitors of mitochondrial protein synthesis would be effective protective agents. The effects of the sulfamoyl derivative of chloramphenicol, Tevenel, which is an antibiotic and an inhibitor of mitochondrial protein synthesis; the optical isomer of chloramphenicol, L-CAP, which is inactive as an antibiotic or as an inhibitor of mitochondrial protein synthesis (Fettes et al., 1972) ; and oxytetracycline, which is an inhibitor of mitochondrial protein synthesis (DeVries and Kroon, 1970) ; are compared with the predictions of the model in Table 1 . Neither oxytetracycline nor Tevenel would significantly prevent the decline of RCR caused by Ccl,. L-CAP, on the other hand, did protect. It is also interesting to note that the effects ofL-CAP and D-CAP were not significantly different from each other, but were inferior to the water-soluble monosuccinate derivative of chloramphenicol, D-CAPS. ' Ccl,-intoxicated rats were injected with the selected drug as described in Methods. Liver mitochondria were prepared after 40 hr of intoxication and the respiratory control ratio (RCR) was determined. Numbers in parentheses indicate numbers of animals used for each determination. D-CAPS, D-CAP, L-CAP, and SKF 525A offered protection, drug-treated vs Ccl, (p < 0.001).
b Not significant, drug-treated vs Ccl4 (p < 0.1). c Not significant, L-chloramphenicol vs o-chloramphenicol (p < 0.1).
To further evaluate the inhibition of mitochondrial protein synthesis as a protective mechanism, the relative effectiveness of D-CAPS and oxytetracycline as inhibitors of mitochondrial protein synthesis in z&o was determined. Mitochondria were isolated and assayed for amino acid incorporation rates at selected periods following injection of either D-CAPS or oxytetracycline. As seen in Table 2 , oxytetracycline was a more potent and persistent inhibitor of mitochondrial protein synthesis than was D-CAPS although neither antibiotic achieved complete inhibition for a prolonged period of time.
The failure of oxytetracycline and Tevenel, and the success of L-CAP in preserving mitochondrial activity during Ccl, intoxication, suggest that the protective abilities of chloramphenicol are being expressed at some point in the cell other than the mitochondrial ribosome. The reports of the inhibition of the microsomal drug metabolizing system by chloramphenicol (Dixon and Fouts, 1962) and the involvement of the microsomal enzymes in intoxication by Ccl, (Recknagel et QI., 1974) point to the endoplasmic reticulum as a possible site of the protective action of the antibiotic. To examine this possibility, the protective abilities of chloramphenicol were compared with those of SKF 525A, a known antagonist of Ccl, intoxication (Cignoli and Castro, 1971; Reynolds and Moslen, 1974) . SKF 525A is a potent inhibitor of microsomal enzyme activity, a mechanism offered to explain its antagonism to intoxication from Ccl,. 4 Rats were injected with the indicated inhibitor or, in the case of oxytetracycline controls, an equal volume of propylene glycol. Hepatic mitochondria were aseptically prepared at selected times later, and incubated with [U-'YJ]leucine. The incorporation of radioactivity into acid-insoluble protein was measured.
b These experiments contained 0.5 pCi/reaction; all others contained 1 &i/reaction.
As may be seen in Table 1 , SKF 525A provided a low level of protection for mitechondria during CCI, intoxication. However, if delivery of SKF 525A occurred 30 min prior to the administration of Ccl,, protection was much more obvious.
The similarity in the antagonism to Ccl, intoxication provided by SKF-52.5A and D-CAPS suggests that D-CAPS may be exerting its action on the microsomal enzymes responsible for activation of CC&. A characteristic membrane lesion of CCI, intoxication is the degranulation of the rough endoplasmic reticulum, and the concomitant inhibition of protein synthesis (Smuckler et al., 1962; Reynolds and Ree, 1971 ). The inhibition is transient, however, and normal rates of synthesis are achieved 20 hr after exposure to CCI,. The effect of D-CAPS on this aspect of CCI, intoxication was examined by monitoring the incorporation of [3,4-3H]leucine into mitochondrial protein in vivo. As seen in Table 3 , Ccl, results in 55 % inhibition of the incorporation of [3,4-3H]leucine into mitochondrial protein 5 hr after administration of CC],. D-CAPS ameliorates this inhibition, allowing only a 30 'A depression. However, when the incorporation of amino acid was examined at a later period (26 hr), animals protected by D-CAPS were incorporating significantly greater amounts of [3,4-3H]leucinc than were control or Ccl,-intoxicated animals. 
DISCUSSION
Chloramphenicol is a potent antagonist of the Ccl,-induced mitochondrial lesion, assuring nearly normal mitochondrial activity during a period of serious disruptive events in the cell. A number of studies relating to antagonism of intoxication by CCI, have been published (Cignoli and Castro, 1971; Dianzani and Ugazio, 1973; Reynolds and Moslen, 1974; Slater and Sawyer, 1969) , including observations that low doses of Ccl,, prior to a toxic dose, act in a protective manner (Dambrauskas and Cornish, 1970; Glende, 1972) . The efficacy of the protective action has been evaluated by morphological, histochemical, and biochemical criteria relating to early events of toxicity, or by increase in the LD50 of Ccl,. Monitoring mitochondrial integrity has not heretofore been a parameter used in evaluating hepatic protective agents, perhaps because the mitochondrial lesion appears late during Ccl, intoxication and therefore is temporally, and spatially, removed from the initial events of intoxication. However, mitochondrial integrity is a convenient and definitive criterion of protection. Mitochondria begin to show loss of function 12-l 5 hr after the administration of Ccl,. The dysfunction intensifies, then disappears coincident with recovery of liver function (Reynolds et al., 1962) . Therefore, the prevention of mitochondrial damage is relevant to survival of the hepatocyte.
D-CAPS has at least two major sites of interaction in the cell (the mitochondria and the endoplasmic reticulum) and both must be considered in a study of its protective action. The failure of Tevenel and oxytetracycline (inhibitors of mitochondrial protein synthesis), and the ability of L-CAP (inactive as an inhibitor of mitochondrial protein synthesis) to prevent the mitochondrial lesion (Table l) , rule against a mechanism of protection (or damage) involving mitochondrial protein synthesis.
On the other hand, involvement of the endoplasmic reticulum is indicated. Figure 2 shows that the protection declines with time after injection of CC14, and is absent by 7 hr, a period that corresponds quite well with the retention of Ccl, in the tissue (Reynolds and Ree, 1971) . D-CAPS is reported to increase the hexobarbital-sleeping time of rats and to inhibit the N-dealkylation of aminopyrine (Dixon and Fouts, 1962) . However, comparison of D-CAPS with SKF 525A, a potent and persistent inhibitor of microsomal drug-metabolizing enzymes, indicates that D-CAPS is a superior protective agent. SKF 525A has been reported by several authors to be one of the most effective inhibitors of early microsomal changes during Ccl, intoxication (Cignoli and Castro, 1971; Reynolds and Moslen, 1974) . As shown in Table 1 , delivery of Ccl, must be delayed 30 min past the time when SKF 525A is administered. Since in our studies Ccl, is delivered ip, the inhibition of the absorption of Ccl, from the intestine by SKF 525A, as suggested by Marchand PI al. (1971) , would not be a likely mechanism for protection.
Studies of the antagonism of Ccl,-induced alterations of the endoplasmic reticulum present a complicated picture. The relationship between biochemical and physiological disturbances in these membranes (e.g., the loss of glucose-6-phosphatase and cytochrome P-450, conjugated dienes in microsomal lipids) and the subsequent cellular pathologies (lipid infiltration, mitochondrial damage, calcium influx) is not clear. If Ccl, is metabolized by a cytochrome P-4.50-requiring enzyme, D-CAPS may inhibit that enzyme system. Cignoli and Castro (1971) could correlate inhibitors of drug metabolism with antagonism to Ccl, toxicity, but noted that exceptions existed. Similarly, destruction of cytochrome P-450 by pretreatment with small doses of Ccl, markedly increased the LD50 of a subsequent toxic dose. Interestingly, the only microsomal parameter significantly altered in the pretreated animals was a decline in conjugated dienes (Recknagel et al., 1974) . Despite the simplicity of the postulate that D-CAPS interrupts Ccl, metabolism, other explanations can be considered to accommodate existing data. In this regard, the conclusion that D-CAPS prevents mitochondrial damage could be erroneous. Table 3 shows that D-CAPS ameliorates, but does not abolish, the CC],-induced loss of protein synthesis. Over 90% of mitochondrial proteins arise on cytoplasmic ribosomes (Beattie, 1971) and even a transitory interruption of protein synthesis could jeopardize the mitochondrion. On the other hand, the rates at which amino acids are incorporated in the protected animals exceeded those of controls at 26 hr (Table 3) , perhaps reflecting increased repair activity. In this interpretation, the preservation of protein synthesis by D-CAPS does not prevent the mitochondrial lesions, but assures that the cell can repair the incipient damage at a rate equal to its production. This would assume that the processes that lead to mitochondrial damage during CCI, intoxication are not the same as those that lead to disruption of protein synthesis, which would be sensitive to interdiction by D-CAPS.
Lastly, observations from longstanding clinical use of D-CAPS predict that few side effects of the drug would be expected at the single, moderate dose (50 mg/kg) that was an effective antagonist to Ccl, in this study, indicating a real potential for therapeutic application in cases of acute intoxication from Ccl,.
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